Biblio
“Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 877-887, 2017.
, “Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1537-1548, 2017.
, “A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 521-537, 2017.
, “Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort.”, J Alzheimers Dis, vol. 57, no. 3, pp. 787-795, 2017.
, “Long-Term Maintenance of Executive-Related Oculomotor Improvements in Older Adults with Self-Reported Cognitive Complaints Following a 24-Week Multiple Modality Exercise Program.”, J Alzheimers Dis, vol. 58, no. 1, pp. 17-22, 2017.
, “Low Arousal Positive Emotional Stimuli Attenuate Aberrant Working Memory Processing in Persons with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1333-1349, 2017.
, “Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 2, pp. 753-762, 2017.
, “Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis?”, J Alzheimers Dis, vol. 60, no. 3, pp. 1097-1106, 2017.
, “Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.”, J Alzheimers Dis, vol. 57, no. 3, pp. 697-703, 2017.
, “Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1045-1054, 2017.
, “Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.”, J Alzheimers Dis, vol. 60, no. 1, pp. 273-281, 2017.
, “Magnetic Resonance Imaging and Anatomical Correlation of Human Temporal Lobe Landmarks, in 3D Euclidean Space: A Study of Control and Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 57, no. 2, pp. 461-473, 2017.
, “The Mechanisms of Action of Curcumin in Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1003-1016, 2017.
, “Meditation and Music Improve Memory and Cognitive Function in Adults with Subjective Cognitive Decline: A Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 3, pp. 899-916, 2017.
, “Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.”, J Alzheimers Dis, vol. 60, no. 2, pp. 401-425, 2017.
, “Memory Complaints and Cognitive Decline: Data from the GUIDAGE Study1.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1567-1578, 2017.
, “Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1119-1128, 2017.
, “Memory is Not Enough: The Neurobiological Substrates of Dynamic Cognitive Reserve.”, J Alzheimers Dis, vol. 58, no. 1, pp. 171-184, 2017.
, “A Meta-Analysis of Memantine for Depression.”, J Alzheimers Dis, vol. 57, no. 1, pp. 113-121, 2017.
, “Meta-Analysis of Parkinson's Disease and Alzheimer's Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1525-1539, 2017.
, “Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 737-748, 2017.
, “A Metal-Free Method for Producing MRI Contrast at Amyloid-β.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1667-1681, 2017.
, “Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 60, no. 1, pp. 43-56, 2017.
, “A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1175-1182, 2017.
, “Methylene Blue (Tetramethylthionine Chloride) Influences the Mobility of Adult Neural Stem Cells: A Potentially Novel Therapeutic Mechanism of a Therapeutic Approach in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 2, pp. 531-540, 2017.
,